Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to conduct a Phase IIa human challenge trial evaluating ...

CoV-2, genetically distinct from the JN.1 lineages that have circulated in the United States since January 2024.

A recent Lancet Microbe study explores intrahost evolution and the risk factors associated with prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised ...

Lung function may shape COVID-19 outcomes in cystic fibrosis transplant recipients. Learn more about the latest findings and ...

Nearly three years since the SARS-CoV-2 pandemic was declared over, conservative estimates suggest that between 80 million ...

Objectives This study aims to estimate the prevalence of long-lasting severe fatigue and identify possible risk factors in a 2-year follow-up of patients with predominantly mild-to-moderate SARS-CoV-2 ...

In a recent study published on the medRxiv* preprint server, researchers conducted blood digital transcriptomics to determine the persistence of severe acute respiratory syndrome coronavirus 2 ...

Credit: Getty Images. Researchers assessed how exercise tolerance, dynamic lung volumes, and quality of life differed over time in individuals who survived SARS-CoV-2 vs SARS-CoV-1. Those who survived ...

COVID-19 infection, compared with influenza, was associated with significantly greater risks for developing AKI, chronic ...

The SARS epidemic may be waning in some of its hot zones in the world, but scientists aren’t ready to put away their petri dishes and declare victory yet. They know, through long experience trying to ...